An Iodine Balance Study to Investigate the Recommended Iodine Intake in an Elderly Population

NCT06218043 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-01-23

No results posted yet for this study

Summary

Current Chinese dietary iodine reference intake (DRIs) standards lack direct data on recommended iodine intake (RNI) in the elderly. The elderly have a high prevalence of thyroid diseases. The risk threshold of iodine intake in the elderly is unknown. Identifying the appropriate iodine intake for the elderly to maintain optimal thyroid function to reduce the burden on medical resources is a public health issue requiring high attention. The iodine balance study is an important method for exploring physiological iodine requirements. Few iodine balance studies have been conducted in the elderly. This study aimed to conduct an iodine balance study and provide information on the appropriate iodine intake level for elderly people.

Conditions

  • Nutrition, Healthy

Interventions

BEHAVIORAL

Restrict subjects' intake of iodine-containing foods

Replace subjects' iodized salt with non-iodized salt.

Sponsors & Collaborators

  • Tianjin Medical University General Hospital

    collaborator OTHER
  • Gansu Provincial Centre for Disease Control and Prevention

    collaborator UNKNOWN
  • Wenxing Guo

    lead OTHER

Principal Investigators

  • Wenxing Guo · Department of Nutrition and Food Hygiene, School of Public Health, Tianjin Medical University

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-06-30
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06218043 on ClinicalTrials.gov